125 related articles for article (PubMed ID: 11215800)
1. Enzymatic degradation of polymer covered SOPC-liposomes in relation to drug delivery.
Davidsen J; Vermehren C; Frøkjaer S; Mouritsen OG; Jørgensen K
Adv Colloid Interface Sci; 2001 Jan; 89-90():303-11. PubMed ID: 11215800
[TBL] [Abstract][Full Text] [Related]
2. Interaction of a lipid-membrane destabilizing enzyme with PEG-liposomes.
Jørgensen K; Kiebler T; Hylander I; Vermehren C
Int J Pharm; 1999 Jun; 183(1):21-4. PubMed ID: 10361147
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery by phospholipase A(2) degradable liposomes.
Davidsen J; Vermehren C; Frokjaer S; Mouritsen OG; Jørgensen K
Int J Pharm; 2001 Feb; 214(1-2):67-9. PubMed ID: 11282239
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of phospholipase A2 catalyzed degradation of polymer grafted PEG-liposomes: effects of lipopolymer-concentration and chain-length.
Jørgensen K; Vermehren C; Mouritsen OG
Pharm Res; 1999 Sep; 16(9):1491-3. PubMed ID: 10496671
[No Abstract] [Full Text] [Related]
5. Increase in phospholipase A2 activity towards lipopolymer-containing liposomes.
Vermehren C; Kiebler T; Hylander I; Callisen TH; Jørgensen K
Biochim Biophys Acta; 1998 Aug; 1373(1):27-36. PubMed ID: 9733909
[TBL] [Abstract][Full Text] [Related]
6. Influence of lipopolymer concentration on liposome degradation and blood clearance.
Vermehren C; Jørgensen K; Frokjaer S
Int J Pharm; 1999 Jun; 183(1):13-6. PubMed ID: 10361145
[TBL] [Abstract][Full Text] [Related]
7. Peroxidation and phospholipase A2 hydrolytic susceptibility of liposomes consisting of mixed species of phosphatidylcholine and phosphatidylethanolamine.
Salgo MG; Corongiu FP; Sevanian A
Biochim Biophys Acta; 1992 Jul; 1127(2):131-40. PubMed ID: 1643097
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase A2 domain formation in hydrolyzed asymmetric phospholipid monolayers at the air/water interface.
Maloney KM; Grandbois M; Grainger DW; Salesse C; Lewis KA; Roberts MF
Biochim Biophys Acta; 1995 May; 1235(2):395-405. PubMed ID: 7756350
[TBL] [Abstract][Full Text] [Related]
9. The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.
Zhang J; Chen Y; Li X; Liang X; Luo X
Int J Nanomedicine; 2016; 11():4187-97. PubMed ID: 27616886
[TBL] [Abstract][Full Text] [Related]
10. Estimation of surface state of poly(ethylene glycol)-coated liposomes using an aqueous two-phase partitioning technique.
Moribe K; Maruyama K; Iwatsuru M
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1683-7. PubMed ID: 9353897
[TBL] [Abstract][Full Text] [Related]
11. Lipid chain length effect on the phase behaviour of PCs/PEG:2000-PEs mixtures. A spin label electron spin resonance and spectrophotometric study.
Belsito S; Bartucci R; Sportelli L
Biophys Chem; 2001 Oct; 93(1):11-22. PubMed ID: 11604213
[TBL] [Abstract][Full Text] [Related]
12. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
13. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer.
Garbuzenko O; Barenholz Y; Priev A
Chem Phys Lipids; 2005 Jun; 135(2):117-29. PubMed ID: 15921973
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase D and phosphatidic acid enhance the hydrolysis of phospholipids in vesicles and in cell membranes by human secreted phospholipase A2.
Kinkaid AR; Othman R; Voysey J; Wilton DC
Biochim Biophys Acta; 1998 Feb; 1390(2):173-85. PubMed ID: 9507109
[TBL] [Abstract][Full Text] [Related]
15. Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery.
Wang R; Xiao R; Zeng Z; Xu L; Wang J
Int J Nanomedicine; 2012; 7():4185-98. PubMed ID: 22904628
[TBL] [Abstract][Full Text] [Related]
16. Interaction between PEG lipid and DSPE/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylation.
Paolino D; Accolla ML; Cilurzo F; Cristiano MC; Cosco D; Castelli F; Sarpietro MG; Fresta M; Celia C
Colloids Surf B Biointerfaces; 2017 Jul; 155():266-275. PubMed ID: 28460301
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation and phospholipase A2 activity in liposomes composed of unsaturated phospholipids: a structural basis for enzyme activation.
Sevanian A; Wratten ML; McLeod LL; Kim E
Biochim Biophys Acta; 1988 Aug; 961(3):316-27. PubMed ID: 3401498
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on the properties of saturated phosphatidylethanolamine and phosphatidylcholine bilayers: barrier characteristics and susceptibility to phospholipase A2 degradation.
Noordam PC; Killian A; Oude Elferink RF; De Gier J
Chem Phys Lipids; 1982 Oct; 31(2):191-204. PubMed ID: 7139847
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes.
Zalipsky S
Bioconjug Chem; 1993; 4(4):296-9. PubMed ID: 8218486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
